4//SEC Filing
Giordano Christopher Thomas 4
Accession 0001654954-24-006744
CIK 0000034956other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:00 PM ET
Size
9.4 KB
Accession
0001654954-24-006744
Insider Transaction Report
Form 4
Giordano Christopher Thomas
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2024-05-17+437→ 437 totalExercise: $3.55Exp: 2034-05-17→ Common Stock (437 underlying)
Holdings
- 157
Stock Option (right to buy)
Exercise: $3152.00Exp: 2031-07-06→ Common Stock (157 underlying) - 125
Stock Option (right to buy)
Exercise: $992.00Exp: 2032-06-09→ Common Stock (125 underlying)
Footnotes (5)
- [F1]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment.
- [F2]These options were previously reported as covering 200,000 shares at an exercise price of $0.62 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
- [F3]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of June 9, 2023, June 9, 2024, June 9, 2025, and June 9, 2026, subject to the Reporting Person's continued employment.
- [F4]These options were previously reported as covering 250,000 shares at an exercise price of $1.97 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
- [F5]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of July 6, 2022, July 6, 2023, July 6, 2024, and July 6, 2025, subject to the Reporting Person's continued employment.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001871714
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:00 PM ET
- Size
- 9.4 KB